HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CJC 1131

amino acid sequence and structure of C-terminal addition in first source

Also Known As:

CJC-1131; CJC1131

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Dicarboxylic Acids: 108
      - Maleates: 3
        Maleimides: 16
        CJC 1131: 3
- Imides: 79
  - Maleimides: 16
    - CJC 1131: 3
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - Maleimides: 16
        CJC 1131: 3
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - CJC 1131: 3

Experts

1.	Cai, Hong-Yan: 1 article (01/2017)
2.	Li, Yu-Feng: 1 article (01/2017)
3.	Ma, Xiao-Wen: 1 article (01/2017)
4.	Qi, Jin-Shun: 1 article (01/2017)
5.	Wang, Zhao-Jun: 1 article (01/2017)
6.	Yuan, Li: 1 article (01/2017)
7.	Zhang, Jun: 1 article (01/2017)
8.	Zhang, Sheng-Xiao: 1 article (01/2017)
9.	Giannoukakis, Nick: 1 article (10/2003)
10.	Baggio, Laurie L: 1 article (03/2003)

Related Diseases

1.	Body Weight (Weight, Body) 03/01/2003 - "Twice daily administration of CJC-1131 to db/db mice significantly reduced glycemic excursion following oral and IP glucose challenge (P < 0.01 to 0.05) but did not significantly lower body weight during the 4-week study period. "
2.	Type 2 Diabetes Mellitus (MODY) 01/01/2017 - "CJC-1131, a newly designed GLP-1 analogue with very longer half-life, has shown good effectiveness in the treatment of type 2 diabetes mellitus (T2DM). " 10/01/2003 - "ConjuChem is developing CJC-1131, a drug affinity complex conjugate of glucagon-like peptide 1 for the potential treatment of type 2 diabetes. "

Related Drugs and Biologics

1.	Glucose (Dextrose)
2.	Glucagon-Like Peptide 1 (GLP 1)